A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants

The expression of antigens in transgenic plants has been increasingly used as an alternative to the classical methodologies for antigen expression in the development of experimental vaccines. However, an important limitation in most cases is the low concentration of the recombinant antigens in the p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Dus Santos, M.J
Otros Autores: Wigdorovitz, A., Trono, K., Ríos, R.D, Franzone, P.M, Gil, F., Moreno, J., Carrillo, C., Escribano, J.M, Borca, M.V
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2002
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 11527caa a22013217a 4500
001 PAPER-5459
003 AR-BaUEN
005 20230518203506.0
008 190411s2002 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0037081390 
024 7 |2 cas  |a Antibodies, Viral; Capsid Proteins; Peptide Fragments; Vaccines, Synthetic; Viral Vaccines; VP1 protein, Foot-and-mouth disease virus 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a VACCD 
100 1 |a Dus Santos, M.J. 
245 1 2 |a A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants 
260 |c 2002 
270 1 0 |m Dus Santos, M.J.; Instituto de Virología, C.I.C.V., INTA-Castelar, Moron (1708), Pcia. de Buenos Aires, Argentina; email: borca@cicv.inta.gov.ar 
506 |2 openaire  |e Política editorial 
504 |a Arakawa, T., Chong, D.K.X., Langridge, W.H.R., Efficacy of a food plant-based oral cholera toxin B subunit vaccine (1998) Nature Biotech, 16, pp. 292-297 
504 |a Carrillo, C., Wigdorovitz, A., Oliveros, J.C., Zamorano, P.I., Sadir, A.M., Gómez, N., Protective immune response to foot and mouth disease virus with VP1 expressed in transgenic plants (1998) J Virol, 72, pp. 1688-1690 
504 |a Castañón, S., Marín, M.S., Martín Alonso, J.M., Boga, J.A., Casais, R., Humara, J.M., Immunization with potato plants expressing VP60 proteins protects against rabbit hemorragic disease virus (1999) J Virol, 73, pp. 4452-4455 
504 |a Fernandez, F., Borca, M.V., Sadir, A., Fondevila, N., Mayo, J., Schudel, A., Foot and mouth disease virus (FMDV) experimental infection: Wusceptibility and immune response of adult mice (1986) Vet Microbiol, 12, p. 15 
504 |a Gómez, N., Carrillo, C., Parra, F., Salinas, J., Borca, M.V., Escribano, J.M., Expression of immunogenic glycoprotein-S-polypeptides from transmissible gastroenteritis coronavirus in transgenic plants (1998) Virology, 249, pp. 352-358 
504 |a Gómez, N., Wigdorovitz, A., Castañón, A., Gil, F., Ordas, R., Borca, M.V., Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus (2000) Arch Virol, 145, pp. 1725-1732 
504 |a Haq, T.A., Mason, H.S., Clements, J.D., Arntzen, C.J., Oral immunization with recombinant bacterial antigen produced in transgenic plants (1995) Science, 268, pp. 714-716 
504 |a Mason, H.S., Lam, D.M.K., Arntzen, C.J., Expression of hepatitis B surface antigen in transgenic plants (1992) Proc Natl Acad Sci USA, 89, pp. 11745-11749 
504 |a Mason, H.S., Ball, J.M., Shi, J.J., Jiang, X., Estes, M.K., Arntzen, C.J., Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice (1996) Proc Natl Acad Sci USA, 93, pp. 5335-5340 
504 |a Mason, H.S., Haq, T.A., Clements, J.D., Arntzen, C.J., Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene (1998) Vaccine, 16, pp. 1335-1342 
504 |a McGarvey, P.B., Hammond, J., Dienelt, M., Hooper, D.C., Fu, Z.F., Dietzschold, B., Expression of rabies virus glycoprotein in transgenic tomatoes (1995) Biotechnology, 13, pp. 1484-1487 
504 |a Wigdorovitz, A., Carrillo, C., Dus Santos, M.J., Sadir, A.M., Ríos, R., Franzione, P., Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunized with alfalfa transgenic plants expressing the viral structural protein VP1 (1999) Virology, 255, pp. 347-353 
504 |a Brown, F., Vaccination against foot and mouth disease virus (1992) Vaccine, 10, pp. 1022-1026 
504 |a Carrillo, C., Wigdorovitz, A., Trono, K., Dus Santos, M.J., Castañón, S., Sadir, A.M., Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants (2001) Viral Immunol, 14, pp. 49-57 
504 |a Zamorano, P., Wigdorovitz, A., Pérez-Filgueira, M., Carrillo, C., Escribano, J.M., Sadir, A.M., A 10 amino acid linear sequence of VP1 of foot and mouth disease virus (FMDV) containing B and T cell epitopes induces protection in mice (1995) Virology, 212, pp. 614-621 
504 |a Wen-Jun, S., Forde, B.G., Efficient transformation of Agrobacterium spp. by high voltage electroporation (1989) Nucl Acid Res, 17, p. 8385 
504 |a Shetty, K., McKersie, B.D., Proline, thioproline and potassium-mediated stimulation of somatic embryogenesis in alfalfa (Medicago sativa L.) (1993) Plant Sci, 88, pp. 185-193 
504 |a McKersie, B.D., Chen, Y., De Beus, M., Bowley, S.R., Superoxide dismutase enhances tolerance of freezing stress in transgenic alfalfa (Medicago sativa L.) (1993) Plant Physiol, 103, pp. 1155-1163 
504 |a Klimyuk, V.I., Carroll, B.J., Thomas, C.M., Jones, J.D.G., Alkali treatment for rapid preparation of plant material for reliable PCR analysis (1993) Plant J, 3, pp. 493-494 
504 |a Gallagher, S.R., The GUS assay (1992) GUS protocols: Using GUS gene as a reporter gene expression, , Gallagher SR, editor 
504 |a Berinstein, A., Piatti, P., Gaggino, O.P., Schudel, A.A., Sadir, A.M., Enhancement of the immune response elicited with foot and mouth disease virus vaccines by an extract of the Mycobacterium sp. wall (1991) Vaccine, 9, pp. 883-888 
520 3 |a The expression of antigens in transgenic plants has been increasingly used as an alternative to the classical methodologies for antigen expression in the development of experimental vaccines. However, an important limitation in most cases is the low concentration of the recombinant antigens in the plant tissues, which reduces the possibilities of practical applications. Because the site of insertion of the transferred DNA into the cellular chromosomal DNA is at random, different levels of foreign protein expression in independent transformants is expected. Strategies to allow the evaluation of a high number of the transgenic individuals, usually an expensive and very time consuming process, would permit the selection of those plants presenting the highest levels of recombinant protein expression. Here, we present the development of an experimental immunogen based in the expression of a highly immunogenic epitope from foot and mouth disease virus (FMDV) fused to the glucuronidase (gus A) reporter gene, which allows selection of the transgenic plants by the ß-glucuronidase (ßGUS) enzymatic activity. We produced transgenic plants of alfalfa expressing the immunogenic site between amino acid residues 135-160 of structural protein VP1 (VP135-160), fused to the ßGUS protein. Plants expressing the highest levels of the immunogenic epitope VP135-160, analyzed by Western blot, were efficiently selected based on their levels of ßGUS enzymatic activity. The FMDV epitope expressed in plants was highly immunogenic in mice which developed, after immunization, a strong anti-FMDV antibody response against a synthetic peptide representing the region VP135-160, to native virus VP1, and to purified FMDV particles. Additionally, these mice were completely protected against experimental challenge with the virulent virus. To our knowledge, this constitutes the first report of a peptide-based vaccine produced in transgenic plants that induces a protective immune response when used in experimental hosts. Also, these results demonstrated the possibility of using a novel and simple methodology for obtaining transgenic plants expressing high levels of foreign immunogenic epitopes, which could be directly applied in the development of plant-based vaccines. © 2002 Elsevier Science Ltd. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Comunidad de Madrid, BIO96-1172 
536 |a Detalles de la financiación: Comisión Interministerial de Ciencia y Tecnología 
536 |a Detalles de la financiación: Authors wish to thank the technical assistance of Mrs. M. A. Palacios and the personnel of Laboratory Bayer in Argentina where the challenge experiments were conducted. This work was supported by Grant BID 802/OC-AR PID 168 from SECYT-CONICET, Rep. Argentina and by Grant 07B/oo14/1999 from Comunidad Autónoma de Madrid, España. This work was supported by Grant BID 802/OC-AR PID 168 from SECYT-CONICET, Rep. Argentina and by Grant BIO96-1172 from Comisión Interministerial de Ciencia y Tecnologı́a de España. 
593 |a Instituto De Virología, C.I.C.V., INTA-Castelar, CC77, Morón (1708), Pcia. De, Buenos Aires, Argentina 
593 |a Instituto De Genética E. A. Favret, C.I.C.A., INTA-Castelar, Buenos Aires, Argentina 
593 |a Centro De Investigación En Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain 
593 |a Facultad De Ciencias Exactas Y Naturales, Universidad De Buenos Aires, Buenos Aires, Argentina 
690 1 0 |a ANTIGEN EXPRESSION 
690 1 0 |a FMDV 
690 1 0 |a RECOMBINANT PLANTS 
690 1 0 |a VACCINATION 
690 1 0 |a AMINO ACID 
690 1 0 |a BETA GLUCURONIDASE 
690 1 0 |a EPITOPE 
690 1 0 |a FOOT AND MOUTH DISEASE VACCINE 
690 1 0 |a PEPTIDE 
690 1 0 |a PROTEIN VP1 
690 1 0 |a ALFALFA 
690 1 0 |a ANALYTIC METHOD 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANTIBODY RESPONSE 
690 1 0 |a ANTIGEN EXPRESSION 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a EXPERIMENTAL HOST 
690 1 0 |a FOOT AND MOUTH DISEASE 
690 1 0 |a FOOT AND MOUTH DISEASE VIRUS 
690 1 0 |a GENE INSERTION 
690 1 0 |a IMMUNE RESPONSE 
690 1 0 |a IMMUNIZATION 
690 1 0 |a IMMUNOGENICITY 
690 1 0 |a METHODOLOGY 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTECTION 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a PROVOCATION TEST 
690 1 0 |a REPORTER GENE 
690 1 0 |a TRANSGENIC PLANT 
690 1 0 |a VACCINE PRODUCTION 
690 1 0 |a VIRUS PARTICLE 
690 1 0 |a VIRUS VIRULENCE 
690 1 0 |a ANIMALS 
690 1 0 |a ANTIBODIES, VIRAL 
690 1 0 |a CAPSID 
690 1 0 |a CAPSID PROTEINS 
690 1 0 |a FOOT-AND-MOUTH DISEASE VIRUS 
690 1 0 |a IMMUNIZATION 
690 1 0 |a MICE 
690 1 0 |a PEPTIDE FRAGMENTS 
690 1 0 |a PLANTS, GENETICALLY MODIFIED 
690 1 0 |a VACCINES, SYNTHETIC 
690 1 0 |a VIRAL VACCINES 
700 1 |a Wigdorovitz, A. 
700 1 |a Trono, K. 
700 1 |a Ríos, R.D. 
700 1 |a Franzone, P.M. 
700 1 |a Gil, F. 
700 1 |a Moreno, J. 
700 1 |a Carrillo, C. 
700 1 |a Escribano, J.M. 
700 1 |a Borca, M.V. 
773 0 |d 2002  |g v. 20  |h pp. 1141-1147  |k n. 7-8  |p Vaccine  |x 0264410X  |w (AR-BaUEN)CENRE-7118  |t Vaccine 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037081390&doi=10.1016%2fS0264-410X%2801%2900434-0&partnerID=40&md5=63be648af88bd61635b3b3bc783c3cf4  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0264-410X(01)00434-0  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_0264410X_v20_n7-8_p1141_DusSantos  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0264410X_v20_n7-8_p1141_DusSantos  |y Registro en la Biblioteca Digital 
961 |a paper_0264410X_v20_n7-8_p1141_DusSantos  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 66412